-
1 Comment
TATA Health International Holdings Limited is currently in a long term uptrend where the price is trading 91.7% above its 200 day moving average.
From a valuation standpoint, the stock is 28.2% more expensive than other stocks from the Consumer Cyclical sector with a price to sales ratio of 6.2.
TATA Health International Holdings Limited's total revenue sank by 47.3% to $79M since the same quarter in the previous year.
Its net income has dropped by 47.6% to $-85M since the same quarter in the previous year.
Finally, its free cash flow grew by 138.6% to $4M since the same quarter in the previous year.
Based on the above factors, TATA Health International Holdings Limited gets an overall score of 2/5.
| ISIN | KYG7998M1033 |
|---|---|
| Exchange | HK |
| CurrencyCode | HKD |
| Sector | Consumer Cyclical |
| Industry | Footwear & Accessories |
| Market Cap | 340M |
|---|---|
| PE Ratio | None |
| Beta | 1.33 |
| Target Price | None |
| Dividend Yield | None |
TATA Health International Holdings Limited, an investment holding company, engages in the wholesale and retail of footwear products in Hong Kong, Taiwan, and Macau. The company operates through Trading of Footwear Products, Trading of Healthcare Products, Financial Services, and Online Medical Services segments. It offers advisory services in securities and corporate finance and investment management services. The company also offers footwear products of various brands comprising Clarks, Josef Seibel, The Flexx, Petite Jolie, shoe mart, S. Culture, and SCOOPS brands. The company was formerly known as S. Culture International Holdings Limited and changed its name to TATA Health International Holdings Limited in November 2020. TATA Health International Holdings Limited was founded in 1974 and is headquartered in Kwai Chung, Hong Kong. TATA Health International Holdings Limited operates as a subsidiary of Great Wall International Investment X Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1255.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
